The Role of PSMA PET Imaging in the Classification of the Risk of Prostate Cancer Patients: A Systematic Review on the Insights to Guide an Active Surveillance Approach.

Détails

Ressource 1Télécharger: 38539457.pdf (989.80 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_38DBC6E5B463
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
The Role of PSMA PET Imaging in the Classification of the Risk of Prostate Cancer Patients: A Systematic Review on the Insights to Guide an Active Surveillance Approach.
Périodique
Cancers
Auteur⸱e⸱s
Dondi F., Antonelli A., Suardi N., Treglia G., Bertagna F.
ISSN
2072-6694 (Print)
ISSN-L
2072-6694
Statut éditorial
Publié
Date de publication
11/03/2024
Peer-reviewed
Oui
Volume
16
Numéro
6
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: epublish
Résumé
active surveillance (AS) is a suitable strategy for patients with prostate cancer (PCa). Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging is an established tool used to assess PCa. The aim of this review was to evaluate the role of PSMA imaging to guide correct risk-based classification and the AS approach in PCa patients.
The Scopus, Embase, Web of Science, Cochrane Library, and PubMed/MEDLINE databases were screened to find relevant published articles.
1774 articles were revealed with the literature search. A total of 1764 articles were excluded after applying exclusion criteria (data not within the field of interest, preclinical papers, conference proceedings, reviews, or editorials). Ten studies were finally included in the review, revealing that PSMA PET could have the ability to guide risk-based classification of PCa and the choice of AS, and to guide the execution of biopsies for the research of high-grade PCa, therefore precluding AS.
this systematic review underlined a possible role of PSMA PET imaging in patients with PCa by correctly re-classifying them on the basis of their risk and guiding AS.
Mots-clé
PET, PSMA, active surveillance, nuclear medicine, positron emission tomography, prostate cancer, prostate-specific membrane antigen
Pubmed
Web of science
Open Access
Oui
Création de la notice
02/04/2024 10:24
Dernière modification de la notice
06/04/2024 7:27
Données d'usage